June 20, 2022Open Access

Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial

Key Points

Key points are not available for this paper at this time.

Abstract

This clinical trial was registered at the Iranian Registry of Clinical Trials (IRCT) with the identifier IRCT ID: IRCT2016070428786N1 registered on August 20, 2016 (Retrospectively registered) ( https://en.irct.ir/trial/23256 ) and at the U.S. National Institutes of Health (ClinicalTrials.gov) with the related identifier NCT04078308 registered on September 6, 2019 (Retrospectively registered). ( https://clinicaltrials.gov/ct2/show/NCT04078308 ).

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Izadi et al. (Mon,) studied this question.

synapsesocial.com/papers/69de6bc7a051b8e25be94028 https://doi.org/https://doi.org/10.1186/s13287-022-02941-w

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper